Trials / Completed
CompletedNCT02137746
Study to Allow for Second Treatment Cycle of DCVAC in Patients With Localized Prostate Cancer
Open-label, One-arm, Multi-centre Phase II Clinical Trial Treated With Second Cycle of Active Cellular Immunotherapy With DCVAC/PCa in Patients With Localized Prostate Cancer After Primary Radical Prostatectomy Without Objective Progression
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- SOTIO a.s. · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety of the second cycle of DCVAC/PCa in patients who completed the first cycle of DCVAC/PCa in the clinical trial SP003 without an objective progression of the disease.
Detailed description
Same as brief summary
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Dendritic Cells DCVAC/PCa | DCVAC/PCa Experimental therapy |
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2015-04-01
- Completion
- 2017-03-20
- First posted
- 2014-05-14
- Last updated
- 2017-05-24
Locations
7 sites across 1 country: Czechia
Source: ClinicalTrials.gov record NCT02137746. Inclusion in this directory is not an endorsement.